title: Author's reply to: Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.
authors.forename: Salvatore
authors.initials: S
authors.lastname: Vaccarella
authors.forename: Gary M
authors.initials: GM
authors.lastname: Clifford
authors.forename: Rebecca
authors.initials: R
authors.lastname: Howell-Jones
authors.forename: Peter J F
authors.initials: PJ
authors.lastname: Snijders
authors.forename: Silvia
authors.initials: S
authors.lastname: Franceschi
mesh_terms: D003430:Cross-Sectional Studies; D018450:Disease Progression; D005260:Female; D006801:Humans; D015337:Multicenter Studies as Topic; D027383:Papillomaviridae / Q000145:classification* / Q000235:genetics; D030361:Papillomavirus Infections / Q000150:complications* / Q000628:therapy / Q000821:virology; D053918:Papillomavirus Vaccines / Q000276:immunology / Q000627:therapeutic use*; D011379:Prognosis; D002583:Uterine Cervical Neoplasms / Q000209:etiology* / Q000628:therapy; D002578:Uterine Cervical Dysplasia / Q000209:etiology* / Q000628:therapy
chemical_list: D053918:Papillomavirus Vaccines